Hypertriglyceridemia
MONDO:0005347A laboratory test result indicating elevated triglyceride concentration in the blood.
Also known as: hypertriglyceridemia, hypertriglyceridemia (disease)
72 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
New pill aims to prevent fat spike after Weight-Loss drug stop
Disease control CompletedThis study tested whether the drug RDX-002 can lower high blood fat levels in people who recently stopped taking weight-loss medications like semaglutide or tirzepatide. Sixty-eight adults who had lost at least 10% of their body weight on those drugs took either RDX-002 or a plac…
Phase: PHASE2 • Sponsor: Response Pharmaceuticals • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drug aims to tame dangerous fat levels in blood
Disease control CompletedThis study tested a drug called pegozafermin in 369 adults with severe hypertriglyceridemia, a condition where blood fat levels are dangerously high. Participants received either the drug or a placebo for 26 weeks. The main goal was to see if the drug could safely lower triglycer…
Phase: PHASE3 • Sponsor: 89bio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New shot shows promise for stubborn high fats in blood
Disease control CompletedThis study tested a drug called olezarsen in 154 adults with high triglycerides (a type of blood fat) and either heart disease or very high triglycerides. Participants received injections of the drug or a placebo for up to 12 months. The main goal was to see if the drug could low…
Phase: PHASE2 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New shot cuts dangerous fat levels in half
Disease control CompletedThis study tested an experimental drug called ARO-APOC3 in 229 adults with severely high triglycerides (a type of blood fat). Participants received two injections of the drug or a placebo. The goal was to see if the drug could safely lower triglyceride levels. Results showed sign…
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New drug aims to lower dangerous fat levels in the blood
Disease control CompletedThis Phase 3 study tested a drug called olezarsen in 1,478 people with very high triglycerides (a type of blood fat) and either heart disease or a high risk for it. Participants received either olezarsen or a placebo as a shot under the skin. The main goal was to see if olezarsen…
Phase: PHASE3 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New shot could tame dangerous blood fats
Disease control CompletedThis Phase 3 trial tested a drug called olezarsen in 617 people with severe hypertriglyceridemia (very high blood fats). Participants received either the drug or a placebo as a shot under the skin. The main goal was to see if olezarsen could lower triglyceride levels more than pl…
Phase: PHASE3 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Could rosemary tea lower blood pressure and fats? new study tests it
Disease control CompletedThis study tested whether drinking rosemary infusion daily for 6 weeks could help people with mild high blood pressure and high triglycerides. 47 adults took part, and researchers measured blood pressure and blood fats before and after. The goal was to see if this simple herbal d…
Phase: NA • Sponsor: awatef Sassi • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New injection shows promise for dangerous fat levels
Disease control CompletedThis study tested a new drug called DR10624 in 79 adults with severely high triglycerides, a type of blood fat that raises the risk of heart problems. Participants received injections under the skin for 12 weeks. The main goal was to see if the drug safely lowers triglyceride lev…
Phase: PHASE2 • Sponsor: Zhejiang Doer Biologics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New drug aims to lower dangerous fats in the blood
Disease control CompletedThis early-stage study tested a new medicine called ARO-ANG3 in 93 people, including healthy volunteers and patients with high cholesterol or high triglycerides. The main goal was to check if the drug is safe and how the body processes it. This research helps determine if the dru…
Phase: PHASE1 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New drug targets dangerous fat levels in blood
Disease control CompletedThis early-stage study tested a new medicine called ARO-APOC3 in healthy volunteers and people with severely high triglycerides or a rare genetic condition called familial chylomicronemia syndrome. The main goal was to check safety and how the drug moves through the body. The stu…
Phase: PHASE1 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New combo drug aims to tackle high cholesterol in one daily pill
Disease control CompletedThis Phase 3 trial tested a new combination drug called Cipros 10 against the standard statin Crestor in 146 adults with dyslipidemia (high cholesterol and triglycerides). The goal was to see if Cipros 10 could lower triglyceride levels more effectively. Participants took one pil…
Phase: PHASE3 • Sponsor: EMS • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New drug MAR001 targets high triglycerides in early trial
Disease control CompletedThis study tested a new medicine, MAR001, in 55 adults with high triglycerides (a type of fat in the blood) and metabolic problems. The main goal was to see if the drug is safe and tolerable. Researchers also checked if it could lower triglyceride levels. The study was completed …
Phase: PHASE1, PHASE2 • Sponsor: Marea Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New shot cuts dangerous fat levels in blood
Disease control CompletedThis study tested a new medicine called olezarsen in 446 people with very high levels of blood fats (triglycerides). The goal was to see if it could lower these fats more than a placebo. Participants received shots under the skin and followed a healthy diet.
Phase: PHASE3 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Fish oil pills tested for lowering fat levels in overweight chileans
Disease control CompletedThis study tested whether low-dose omega-3 supplements (250 mg EPA per day) can improve cholesterol and inflammation in overweight or obese adults with high triglycerides. Forty participants in Chile took omega-3 or a placebo for six weeks each in a crossover design. The goal was…
Phase: NA • Sponsor: Universidad San Sebastián • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Fish oil and exercise: a One-Two punch against obesity inflammation?
Disease control CompletedThis study looked at whether taking fish oil and doing high-intensity interval training (HIIT) could lower inflammation in people who are overweight or obese. Researchers measured changes in blood markers of inflammation and metabolism over 10 weeks. The goal was to see if the co…
Phase: NA • Sponsor: Texas Tech University • Aim: Disease control
Last updated Jun 26, 2026 16:24 UTC
-
New cholesterol drug VSA003 passes first safety test in healthy volunteers
Disease control CompletedThis early-phase study tested a single dose of VSA003 in 36 healthy Chinese adults to see if it is safe and how the body handles it. The drug aims to help control high cholesterol and triglycerides. Participants received either VSA003 or a placebo, and researchers monitored for s…
Phase: PHASE1 • Sponsor: Visirna Therapeutics HK Limited • Aim: Disease control
Last updated Jun 26, 2026 15:39 UTC
-
Gene hunt for rare cholesterol problems
Knowledge-focused CompletedThis study aimed to find new gene changes that cause rare lipid disorders. Researchers used advanced genetic testing to look at many genes at once in 140 people and their relatives. The goal was to discover causes that older methods missed.
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Yogurt and cheese may boost insulin sensitivity, study finds
Knowledge-focused CompletedThis study looked at whether replacing non-dairy foods with two servings a day of full-fat or low-fat fermented dairy (like yogurt and cheese) could improve insulin sensitivity and other heart health markers. 110 overweight adults with high triglycerides took part. The goal was t…
Phase: NA • Sponsor: Midwest Center for Metabolic and Cardiovascular Research • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Diet study reveals why some lose more weight than others
Knowledge-focused CompletedThis completed study looked at how a low-calorie diet changes the activity of certain genes in white blood cells and affects heart health markers in 60 people with high triglycerides and overweight. Researchers compared those who lost more weight to those who lost less, to unders…
Phase: NA • Sponsor: Shahid Beheshti University of Medical Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Researchers investigate Cortisol's role in rare fat disorder
Knowledge-focused CompletedThis study looked at how the body processes cortisol in people with a rare genetic condition called familial partial lipodystrophy type 2 (FPL2). The goal was to see if increased activity of a certain enzyme (11β-HSD1) contributes to the severe metabolic problems seen in this dis…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Study reveals HPV vaccine gaps in teens with chronic illness
Knowledge-focused CompletedThis study looked at how many girls and young women aged 11 to 20 with chronic diseases (like diabetes or immune conditions) got the HPV vaccine, compared to those without chronic illness. Researchers reviewed records of 223 participants from a hospital in France. The goal was to…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC